|
Real-time Estimate
Cboe BZX
14:45:58 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 69.56 USD | +0.99% |
|
+7.03% | -15.31% |
| 08-12 | Oppenheimer Adjusts PT on Tarsus Pharmaceuticals to $100 From $97, Keeps Outperform Rating | MT |
| 08-07 | Mizuho Adjusts Tarsus Pharmaceuticals PT to $100 From $98, Maintains Outperform Rating | MT |
| Market Cap | 3.02B 2.61B 2.45B 2.23B 4.19B 289B 4.26B 28.74B 11.24B 145B 11.35B 11.1B 481B | P/E 2026 * |
-32.3x | P/E 2027 * | 29.6x |
|---|---|---|---|---|---|
| Enterprise Value | 3.02B 2.61B 2.45B 2.23B 4.19B 289B 4.26B 28.74B 11.24B 145B 11.35B 11.1B 481B | EV / Sales 2026 * |
4.24x | EV / Sales 2027 * | 3.27x |
| Free-Float |
97.13% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Tarsus Pharmaceuticals, Inc.
| 1 day | +0.83% | ||
| 1 week | +7.03% | ||
| Current month | +17.45% | ||
| 1 month | +23.59% | ||
| 3 months | +6.39% | ||
| 6 months | +10.46% | ||
| Current year | -15.31% |
| 1 week | 62.85 |  | 71.34 |
| 1 month | 53.89 | | 71.34 |
| Current year | 53.89 | | 83.92 |
| 1 year | 48.2 | | 85.25 |
| 3 years | 12.57 | | 85.25 |
| 5 years | 10.8 | | 85.25 |
| 10 years | 10.8 | | 85.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bobak Azamian
CEO | Chief Executive Officer | 48 | 2018-08-31 |
Jeffrey Farrow
DFI | Director of Finance/CFO | 64 | 2023-04-23 |
| Chief Tech/Sci/R&D Officer | 47 | 2024-11-03 |
| Director | Title | Age | Since |
|---|---|---|---|
Bobak Azamian
CHM | Chairman | 48 | 2022-12-01 |
| Director/Board Member | 71 | 2019-11-30 | |
Bill Link
BRD | Director/Board Member | 80 | 2016-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 3/17/26 | Sell | Chief Financial Officer | 6,430 | 0.0151% | ||
| 3/17/26 | Sell | General Counsel | 12,440 | 0.0292% | ||
| 3/15/26 | Fiscal year | Chief Operating Officer | 52,574 | 0.1235% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.99% | +7.03% | +28.08% | +312.03% | 3.02B | |
| -0.20% | +2.65% | +42.26% | -0.40% | 80.48B | |
| -1.02% | +2.25% | -3.19% | +25.69% | 51.06B | |
| -3.10% | -4.84% | +9.26% | +158.46% | 48.19B | |
| -0.74% | +3.13% | -49.36% | -48.70% | 46.5B | |
| -0.31% | +1.03% | +55.69% | -22.97% | 31.12B | |
| -0.06% | +7.02% | +137.26% | -36.67% | 25.41B | |
| -0.42% | -0.31% | +39.49% | +84.23% | 24.43B | |
| -1.42% | +3.13% | -1.26% | +182.96% | 21.11B | |
| -1.83% | -2.82% | +61.91% | +105.60% | 16.28B | |
| Average | -0.82% | +3.71% | +32.02% | +76.02% | 34.76B | |
| Weighted average by Cap. | -0.94% | +2.98% | +24.86% | +39.09% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 714M 616M 579M 527M 990M 68.24B 1.01B 6.79B 2.65B 34.17B 2.68B 2.62B 114B | 925M 799M 751M 683M 1.28B 88.48B 1.31B 8.8B 3.44B 44.31B 3.47B 3.4B 147B |
| Net income | -95.74M -82.69M -77.7M -70.66M -133M -9.15B -135M -910M -356M -4.58B -359M -352M -15.23B | 116M 100M 94.08M 85.56M 161M 11.08B 164M 1.1B 431M 5.55B 435M 426M 18.45B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-14 | US$69.45 | +0.82% | 233,157 |
| 26-08-13 | US$68.88 | -1.62% | 631,791 |
| 26-08-12 | US$70.02 | +0.80% | 1,017,402 |
| 26-08-11 | US$69.46 | +2.51% | 740,801 |
| 26-08-10 | US$67.76 | +4.58% | 947,744 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TARS Stock
Select your edition
All financial news and data tailored to specific country editions
